Erratum: Blood flow reprograms lymphatic vessels to blood vessels (Journal of Clinical Investigation (2012) 122, 6 (2006-2017) DOI: 10.1172/JCI57513);Blood flow reprograms lymphatic vessels to blood vessels

Journal of Clinical Investigation

Volumn 122, Issue 6, 2012, Pages 2006-2017

  Chen, Chiu Yu ^a   Bertozzi, Cara ^a   Zou, Zhiying ^a   Yuan, Lijun ^a   Lee, John S ^a   Lu, MinMin ^a   Stachelek, Stan J ^b   Srinivasan, Sathish ^c   Guo, Lili ^a   Vincente, Andres ^d   Mericko, Patricia ^a   Levy, Robert J ^b   Makinen, Taija ^d   Oliver, Guillermo ^c   Kahn, Mark L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; HOMEODOMAIN PROTEIN; PROSPERO HOMEOBOX 1; PROTEIN SH2; PROTEIN SLP 76; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CARDIOVASCULAR DISEASE; CELL LINEAGE; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; GENE MUTATION; HEMODYNAMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LYMPH VESSEL; MESENTERY BLOOD VESSEL; MOUSE; NEWBORN; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SHEAR STRESS;

EID: 84861794046     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65314     Document Type: Erratum

References (47)

1. Friedlander RM. Clinical practice. Arteriovenous malformations of the brain. N Engl J Med. 2007; 356(26):2704-2712. (Pubitemid 47001039)
2. Peery WH. Clinical spectrum of hereditary hemor-rhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med. 1987;82(5):989-997.
3. Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part I. J Am Acad Dermatol. 2007;56(3):353-370.
4. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007; 16(spec no. 2):R140-R149.
5. Oda T, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997;16(3):235-242.
6. McAllister KA, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994;8(4):345-351.
7. Sahoo T, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet. 1999;8(12):2325-2333. (Pubitemid 29525349)
8. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development. 2002; 129(4):1075-1082. (Pubitemid 34874130)
9. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest. 1999;104(10):1343-1351.
10. Abtahian F, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 2003;299(5604):247-251. (Pubitemid 36125210)
11. Bertozzi CC, et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 2010;116(4):661-670.
12. Turner M, et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 1995;378(6554):298-302.
13. Clements JL, et al. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest. 1999;103(1):19-25. (Pubitemid 29031159)
14. Sabin FR. On the origin of the lymphatic system from the veins, and the development of the lymph hearts and thoracic duct in the pig. Am J Anat. 1902;1(3):367-389.
15. Srinivasan RS, et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 2007;21(19):2422-2432. (Pubitemid 47529372)
16. Kim KE, Sung HK, Koh GY. Lymphatic development in mouse small intestine. Dev Dyn. 2007; 236(7):2020-2025.
17. Wigle JT, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. Embo J. 2002;21(7):1505-1513. (Pubitemid 34614607)
18. Johnson NC, et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 2008;22(23):3282-3291.
19. Kriehuber E, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 2001;194(6):797-808. (Pubitemid 32983015)
20. Petrova TV, et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox- 1 homeobox transcription factor. Embo J. 2002; 21(17):4593-4599. (Pubitemid 34984346)
21. Banerji S, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144(4):789-801. (Pubitemid 29234556)
22. Nelson GM, Padera TP, Garkavtsev I, Shioda T, Jain RK. Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia. 2007;9(12):1038-1045. (Pubitemid 350255352)
23. Jiang S, et al. Hematopoietic stem cells contribute to lymphatic endothelium. PLoS One. 2008;3(11):e3812.
24. Stadtfeld M, Graf T. Assessing the role of hemato-poietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development. 2005;132(1):203-213. (Pubitemid 40207979)
25. Bazigou E, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009;17(2):175-186.
26. Bazigou E, et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest. 2011;121(8):2984-2992.
27. Abtahian F, et al. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol. 2006;26(18):6936-6949. (Pubitemid 44387642)
28. Vogel J, et al. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood. 2003;102(6):2278-2284. (Pubitemid 37122410)
29. Gnasso A, et al. Association between intima-media thickness and wall shear stress in common carotid arteries in healthy male subjects. Circulation. 1996;94(12):3257-3262. (Pubitemid 26427496)
30. Irace C, Cortese C, Fiaschi E, Carallo C, Farinaro E, Gnasso A. Wall shear stress is associated with intima- media thickness and carotid atherosclerosis in subjects at low coronary heart disease risk. Stroke. 2004;35(2):464-468. (Pubitemid 38174431)
31. Buschmann I, et al. Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow-driven arteriogenesis. Development. 2010; 137(13):2187-2196.
32. le Noble F, et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development. 2004;131(2):361-375.
33. Kwei S, et al. Early adaptive responses of the vascular wall during venous arterialization in mice. Am J Pathol. 2004;164(1):81-89. (Pubitemid 38364593)
34. Caplan BA, Schwartz CJ. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis. 1973;17(3):401-417.
35. Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A. 1976;73(2):651-653.
36. Walter DH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002; 105(25):3017-3024. (Pubitemid 34693836)
37. Iwakura A, et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation. 2003;108(25):3115-3121. (Pubitemid 38031801)
38. Ii M, et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res. 2006;98(5):697-704.
39. Sahara M, et al. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury. Stem Cells. 2005;23(7):874-878. (Pubitemid 41170943)
40. Kang J, et al. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood. 2010;116(1):140-150.
41. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004;18(8):901-911. (Pubitemid 38529659)
42. Jones EA, le Noble F, Eichmann A. What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology (Bethesda). 2006;21:388-395. (Pubitemid 44879247)
43. Parmar KM, et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116(1):49-58. (Pubitemid 43121790)
44. Jones EA, Yuan L, Breant C, Watts RJ, Eichmann A. Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. Development. 2008;135(14):2479-2488.
45. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature. 2010;464(7292):1196-1200.
46. Veikkola T, et al. Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. Faseb J. 2003;17(14):2006- 2013. (Pubitemid 37392445)
47. Richard L, Velasco P, Detmar M. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res. 1998;240(1):1-6. (Pubitemid 28366604)